ANA5 Funnel Catheter has received the CE Mark certification
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
| wordpress_test_cookie | session | Used on sites built with Wordpress. Tests whether or not the browser has cookies enabled |
Anaconda Biomed is proud to announce that its ANA5 Funnel Catheter has been awarded CE Mark certification, authorizing its commercial distribution across Europe. The ANA5 is designed to advance the standard of care in mechanical thrombectomy for ischemic stroke.
With its distinctive funnel-shaped geometry, the ANA5 aims to maximize clot capture, improve first-pass recanalization rates, and support physicians in achieving more effective and efficient procedures. This regulatory milestone marks a significant step in Anaconda Biomed’s mission to deliver innovative solutions for neurovascular diseases.
The CE Mark approval reflects the company’s commitment to quality, innovation, and improving outcomes for patients suffering from stroke.